| Mr Daniel E Clayton, CRNA | |
|
5595 Topaz St, Alta Loma, CA 91701-1910 | |
| (909) 466-0511 | |
| Not Available |
| Full Name | Mr Daniel E Clayton |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 5595 Topaz St, Alta Loma, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710176342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 508674 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barstow Community Hospital | Barstow, CA | Hospital |
| Sutter Coast Hospital | Crescent city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| G And G Anesthesia Llc | 4981912607 | 69 |
| Sda Services Of Ca | 5496094823 | 15 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Safety for people with food allergies will be boosted later this month when new European laws will force manufacturers to label their food more accurately, but the laws do not offer full protection, says an editorial in the British Medical Journal (BMJ).
Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).
› Verified 4 days ago
| Entity Name | Sda Services Of Ca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417428970 PECOS PAC ID: 5496094823 Enrollment ID: O20190302000074 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Safety for people with food allergies will be boosted later this month when new European laws will force manufacturers to label their food more accurately, but the laws do not offer full protection, says an editorial in the British Medical Journal (BMJ).
Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).
› Verified 4 days ago
| Entity Name | G & G Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487020111 PECOS PAC ID: 4981912607 Enrollment ID: O20200512001499 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Safety for people with food allergies will be boosted later this month when new European laws will force manufacturers to label their food more accurately, but the laws do not offer full protection, says an editorial in the British Medical Journal (BMJ).
Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Daniel E Clayton, CRNA 5595 Topaz St, Alta Loma, CA 91701-1910 Ph: (909) 466-0511 | Mr Daniel E Clayton, CRNA 5595 Topaz St, Alta Loma, CA 91701-1910 Ph: (909) 466-0511 |
News Archive
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Safety for people with food allergies will be boosted later this month when new European laws will force manufacturers to label their food more accurately, but the laws do not offer full protection, says an editorial in the British Medical Journal (BMJ).
Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).
› Verified 4 days ago